Physician profile

John Kim

Pulmonary Disease · Montclair, CA

NPI 1710206024

$6,285.03

in general payments reported to CMS, 2019-2025

30 companies · $2,365 in 2025

The $2,365 reported for 2025 was more than what 79% of Pulmonary Disease providers received nationally (typical 2025 total: $500).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$4,610.14
Education$68.89

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Glaxosmithkline, LLC. $1,715.50 2019-2025 Trelegy Ellipta, Nucala, Shingrix
Astrazeneca Pharmaceuticals Lp $812.67 2020-2025 Fasenra, Breztri, Tezspire
Genzyme Corporation $470.11 2022-2025
Regeneron Healthcare Solutions, INC. $466.47 2021-2025 Dupixent
Bayer Healthcare Pharmaceuticals INC. $417.17 2019-2023
Boehringer Ingelheim Pharmaceuticals, INC. $378.64 2021-2025 Ofev, Stiolto Respimat, Jascayd
Actelion Pharmaceuticals US, INC. $245.16 2023-2025 Uptravi, Opsumit, Opsynvi
Verona Pharma, INC. $229.33 2025 Ohtuvayre
Insmed, INC. $224.59 2023-2025 Arikayce, Brinsupri
Merck Sharp & Dohme LLC $196.41 2023-2025 Winrevair, Zerbaxa
United Therapeutics Corporation $194.01 2019-2025 Tyvaso, Tyvaso, Orenitram
Viatris Specialty LLC $146.60 2025 Yupelri
Baxter Healthcare $135.14 2024-2025 Hillrom - Volara System, Hillrom - Monarch Airway Clearance System
Janssen Pharmaceuticals, INC $122.24 2019-2022
Philips North America LLC $104.24 2022-2025 (8874) Incourage, Respiratory
Show all 30 companies
CompanyGeneral paymentsYearsTop products
Amgen INC. $80.05 2022-2025 Tezspire
Vifor Pharma, INC. $54.93 2021
Electromed, INC. $36.89 2023-2025 Smartvest
Shionogi INC $35.60 2021-2023 Fetroja
Ani Pharmaceuticals, INC. $34.48 2025 Purified Cortrophin Gel
Genentech USA, INC. $28.20 2022
Phadia US INC. $23.07 2024 Immunocap
Salix Pharmaceuticals, A Division of Bausch Health US, LLC $21.24 2022
Inogen, INC. $19.82 2023 Inogen One G5 Oxygen Concentrator - Bluetooth
Mylan Specialty L.P. $19.79 2024 Yupelri
Dexcom, INC. $15.96 2025 Dexcom G6 Transmitter
Gilead Sciences, INC. $15.69 2024
Novartis Pharmaceuticals Corporation $14.54 2024
Paratek Pharmaceuticals, INC. $14.49 2025 Nuzyra
Melinta Therapeutics, LLC $12.00 2019

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

John Kim

$6,285.03

in general payments reported 2019-2025

Years
2019-2025
Top company
Glaxosmithkline, LLC.
Context
The $2,365 reported for 2025 was more than what 79% of Pulmonary Disease providers received nationally (typical 2025 total: $500).

https://glasscript.com/doctor/5225872/john-kim

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.